{"organizations": [], "uuid": "0864705dce2a2f32eaa1ed634e16c7b50b306322", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-boston-scientific-announces-prelim/brief-boston-scientific-announces-preliminary-unaudited-sales-for-q4-and-fy17-idUSASB0C0AU", "country": "US", "domain_rank": 408, "title": "BRIEF-Boston Scientific Announces Preliminary Unaudited Sales For Q4 and FY17", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-09T13:48:00.000+02:00", "replies_count": 0, "uuid": "0864705dce2a2f32eaa1ed634e16c7b50b306322"}, "author": "", "url": "https://www.reuters.com/article/brief-boston-scientific-announces-prelim/brief-boston-scientific-announces-preliminary-unaudited-sales-for-q4-and-fy17-idUSASB0C0AU", "ord_in_thread": 0, "title": "BRIEF-Boston Scientific Announces Preliminary Unaudited Sales For Q4 and FY17", "locations": [], "entities": {"persons": [], "locations": [{"name": "boston", "sentiment": "none"}], "organizations": [{"name": "reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "boston scientific corp", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 9, 2018 / 11:50 AM / Updated 16 minutes ago BRIEF-Boston Scientific Announces Preliminary Unaudited Sales For Q4 and FY17 Reuters Staff 1 Min Read \nJan 9 (Reuters) - Boston Scientific Corp: \n* BOSTON SCIENTIFIC ANNOUNCES PRELIMINARY UNAUDITED SALES FOR THE FOURTH QUARTER AND FULL YEAR ENDED DECEMBER 31, 2017 \n* Q4 SALES $2.41 BILLION VERSUS I/B/E/S VIEW $2.35 BILLION Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-09T13:48:00.000+02:00", "crawled": "2018-01-09T14:10:33.067+02:00", "highlightTitle": ""}